Welcome to our dedicated page for 3D Systems news (Ticker: DDD), a resource for investors and traders seeking the latest updates and insights on 3D Systems stock.
3D Systems Corp (symbol: DDD) is a pioneer in the 3D printing industry, offering a broad array of 3D printing and digital manufacturing solutions. The company's product portfolio includes 3D printers for plastics and metals, materials, software, on-demand manufacturing services, and digital design tools. With over 35 years of experience, 3D Systems is at the forefront of innovation in additive manufacturing, impacting a wide range of industries from healthcare and dental to aerospace, automotive, and durable goods.
3D Systems' operations are segmented into Healthcare Solutions and Industrial Solutions, with a significant portion of its revenue generated from the Industrial segment. The company has a strong global presence with offices and facilities across the Americas, EMEA, and APAC regions, although the majority of its revenue comes from the Americas.
The company's recent projects have showcased its advanced capabilities in both industrial and healthcare applications. For instance, 3D Systems has pioneered a first-to-market solution for jetted, monolithic dentures, combining bespoke materials to deliver high-performance dental prosthetics. This innovation has gained interest from leading dental labs and is expected to receive FDA clearance in the second half of 2024.
On the industrial front, 3D Systems continues to expand its portfolio. Recently, the company has seen growth in its metal 3D printing division with Wilting, an industrial machining and metal 3D printing service provider, adding multiple DMP Flex 350 metal 3D printers to its production line. This expansion will enable Wilting to meet increasing customer demand more efficiently.
Financially, 3D Systems has been proactive in managing its liabilities and maintaining a strong balance sheet. The company recently entered into repurchase agreements to buy back $110 million of its 0% Convertible Senior Notes due 2026, thereby reducing its outstanding debt significantly.
3D Systems' commitment to innovation is further exemplified by its developments in patient-specific medical devices. The FDA recently cleared its VSP® PEEK Cranial Implant solution, designed for use in cranioplasty procedures, which utilizes additive manufacturing to produce highly customized, cost-effective cranial implants.
Looking ahead, 3D Systems aims to harness its leadership in digital dentistry, with plans to expand its product offerings to include night guards and direct-printed clear aligners. The company has also secured a multi-year purchase agreement, valued at nearly a quarter-billion dollars, to support the indirect manufacturing process for clear aligners, a testament to its robust 3D printing technology and market leadership.
3D Systems' unique combination of hardware, software, materials, and services, powered by expert application engineers, ensures they continue to transform industries and empower their customers to innovate. More information on 3D Systems is available at www.3dsystems.com.
3D Systems announced a delay in filing its Annual Report on Form 10-K due to cash flow presentation issues related to the divestiture of its Cimatron and GibbsCam software businesses. Despite this, the company reported a Q4 2020 revenue of $172.7 million, a 2.6% increase from Q4 2019, driven by a 48% growth in its Healthcare segment. Overall FY 2020 revenue was $557.2 million, down 12.4% from 2019 due to COVID-19 impacts. The company anticipates gross profit margins between 40% and 44% for 2021, with improved liquidity and cost savings initiatives enhancing future prospects.
3D Systems (NYSE:DDD) has launched its High Speed Fusion (HSF) industrial 3D printer platform, developed in collaboration with Jabil Inc. The new Roadrunner printer promises printing speeds three times faster than standard systems while achieving high precision. With capabilities for high-temperature materials, the marketplace for these solutions is valued at over $400 million. This innovation aims to cater to demanding sectors like aerospace and automotive, addressing previous limitations of high production costs and low throughput.
3D Systems (DDD) has delayed its fourth quarter and full year 2020 conference call, now set for March 2, 2021, after filing financial results on March 1, 2021. The company reaffirmed preliminary revenue expectations for Q4 2020 between $170M to $176M, and a GAAP operating loss ranging from $(8.6)M to $0.5M. Notably, the company may report internal control deficiencies, potentially indicating material weaknesses in its fiscal 2020 Annual Report.
3D Systems (NYSE: DDD) has been selected by Raytheon Technologies and the U.S. Army Research Laboratory to assist in a project aimed at optimizing additively manufactured parts for military applications. This innovative research will focus on improving heat transfer and overall system performance using 3D Systems' DMP Factory 500 metal 3D printing solution. The initiative aims to enhance the Army's modernization efforts by integrating advanced technologies in design, monitoring, and data security.
3D Systems (NYSE: DDD) is increasing its investment in regenerative medicine and bioprinting, driven by advancements with United Therapeutics. The collaboration aims to create 3D-printed lung scaffolds with vascularization to support living cells. Significant technology improvements enable broad applications in regenerative medicine, reducing reliance on animal testing for drug development. The company plans to expand resources in R&D and enhance its partner network, focusing on innovative applications that meet critical healthcare needs.
3D Systems (NYSE: DDD) announced the completion of the sale of its Cimatron and GibbsCAM software businesses for approximately $64 million, using part of the proceeds to repay its senior secured term loan, eliminating debt. The company reported strong preliminary Q4 2020 revenues expected between $170 million and $176 million, with over 20% organic growth in both Healthcare and Industrial units. Non-GAAP operating income is projected at $11-$19 million, significantly improving from Q4 2019. The firm will release detailed Q4 results on February 24, 2021.
3D Systems (NYSE:DDD) will present at the Needham Virtual Growth Conference on January 13, 2021, at 10:45 a.m. Eastern Time. A live webcast of the presentation will be accessible on the company's Investor Relations website and available for replay for 30 days after the event. The release includes forward-looking statements regarding potential risks and uncertainties that may affect future performance. For more details about 3D Systems and its additive manufacturing solutions, visit 3dsystems.com.
3D Systems (NYSE: DDD) has launched its Environmental, Social & Governance (ESG) initiative, reinforcing its commitment to global sustainability, social responsibility, and ethical governance. The initiative includes plans to reduce carbon emissions by optimizing manufacturing processes and advocating for sustainable practices. The company aims to achieve a lower environmental impact through additive manufacturing. Additionally, 3D Systems has committed to supporting social causes and maintaining high ethical standards within its operations.
3D Systems (NYSE: DDD) has appointed Dr. Vasant Padmanabhan to its Board of Directors, effective immediately. Dr. Padmanabhan brings nearly three decades of experience in R&D and operations, notably from his role as president of global R&D at Smith & Nephew. His expertise in the medical device sector is expected to support 3D Systems' focus on additive manufacturing in healthcare. Dr. Padmanabhan is enthusiastic about the company's transformation and innovation initiatives, which aim to enhance healthcare solutions.
3D Systems has received FDA 510(k) clearance for its Vantage® Ankle Patient-Specific Instrumentation (PSI), designed to streamline total ankle replacement surgeries. This product, developed in collaboration with Exactech, reduces the number of procedural steps and operation room time, enhancing overall surgical efficiency and soft-tissue preservation. The Vantage Ankle PSI offers a unique patient-specific approach, enabling direct osteotomies and better visualization of the surgical area. Full market availability is expected by late 2021 after a pilot launch.
FAQ
What is the current stock price of 3D Systems (DDD)?
What is the market cap of 3D Systems (DDD)?
What does 3D Systems Corp do?
What are the main segments of 3D Systems' business?
What recent innovations has 3D Systems introduced?
How is 3D Systems expanding its digital dentistry portfolio?
What is the significance of 3D Systems' recent debt repurchase?
How does 3D Systems impact the healthcare industry?
What are some of the industries served by 3D Systems?
Where does 3D Systems generate most of its revenue?
What is 3D Systems' approach to supporting customer demand?
How long has 3D Systems been in the 3D printing industry?
